PepGen Inc
PepGen is a clinical-stage biotechnology company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide platform, which uses cell-penetrating peptides to improve oligonucleotide uptake and activity.
8-KNov 12Latest SEC filing
Nov 10Latest story
November 2026
August 2026